Pure Biologics Spólka Akcyjna reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was PLN 18.03 million compared to PLN 16.66 million a year ago. Net loss was PLN 11.77 million compared to PLN 11.76 million a year ago.

Basic loss per share from continuing operations was PLN 5.3 compared to PLN 7.11 a year ago.